Dataset Information


FOXP2 contributes to the cognitive impairment in chronic patients with schizophrenia.

ABSTRACT: The forkhead-box P2 (FOXP2), involving in language and memory function, has been identified as susceptibility to schizophrenia. However, no study examined the role of FOXP2 on cognitive impairment in schizophrenia. Total 1106 inpatients with schizophrenia and 404 controls were recruited and genotyped. Among them, 867 patients and 402 controls were assessed through the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). SHEsis software was used to investigate the association of FOXP2 rs10447760 with schizophrenia, followed by logistic regression. The model of covariance (ANCOVA) and multivariate analysis were conducted to investigate the effect of FOXP2 rs10447760 on cognitive impairment in schizophrenia. No differences in the genotypic and allelic frequencies of the FOXP2 rs10447760 were found between patients and controls (both p> 0.05). Except for the visuospatial/constructional score (p > 0.05), other five RBANS scores were lower in patients compared to controls (all p < 0.0001). Interestingly, we found immediate memory score was lower in patients carrying genotype CT compared to genotype CC (F=5.19, p=0.02), adjusting for confounding data. Our study suggested that FOXP2 rs10447760 has no effect on the susceptibility to schizophrenia, while it may be associated with its cognitive impairment, especially immediate memory in chronic schizophrenia.


PROVIDER: S-EPMC6738427 | BioStudies | 2019-01-01


REPOSITORIES: biostudies

Similar Datasets

2012-01-01 | S-EPMC3343009 | BioStudies
2012-01-01 | S-EPMC3671849 | BioStudies
2018-01-01 | S-EPMC5790490 | BioStudies
2016-01-01 | S-EPMC5104293 | BioStudies
2020-01-01 | S-EPMC7031513 | BioStudies
2014-01-01 | S-EPMC3984504 | BioStudies
1000-01-01 | S-EPMC6168951 | BioStudies
1000-01-01 | S-EPMC4509840 | BioStudies
2019-01-01 | S-EPMC6338731 | BioStudies
2020-01-01 | S-EPMC7518064 | BioStudies